All Stories

  1. Gene modification: Exploring the potential in treating kidney diseases
  2. Endothelial cell–released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome
  3. Lived experience is essential for innovation in biomedical research
  4. Induction of plasmalemmal vesicle-associated protein exacerbates glomerular endothelial injury in thrombotic microangiopathy
  5. Aging kidneys reveal underlying mechanisms of endothelial dysfunction
  6. Integrity of the Glomerular Filtration Barrier
  7. Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease
  8. Open-Source System for Real-Time Functional Assessment of In Vitro Filtration Barriers
  9. Redox regulation in diabetic kidney disease
  10. Effect of Aging and a Dual Orexin Receptor Antagonist on Sleep Architecture and Non-REM Oscillations Including an REM Behavior Disorder Phenotype in the PS19 Mouse Model of Tauopathy
  11. Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR
  12. Insights into glomerular function and disease pathogenesis
  13. Editorial: Molecular mechanisms of proteinuria, volume II
  14. Podocyte as the link between sterile inflammation and diabetic kidney disease
  15. Isolation of Conditionally Immortalized Mouse Glomerular Endothelial Cells with Fluorescent Mitochondria
  16. Tackling chronic kidney disease in diabetic patients with finerenone
  17. Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation
  18. Disability innovation strengthens STEM
  19. The glomerular filtration barrier: a structural target for novel kidney therapies
  20. Clues to Glomerular Cell Chatter in Focal Segmental Glomerulosclerosis: Via Endothelin-1/ETR
  21. Modeling the Glomerular Filtration Barrier and Intercellular Crosstalk
  22. Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction
  23. The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes
  24. Mitochondria Matters: A Critical Role of ADCK4 in Stabilizing the CoQ Complex in Podocytes in Steroid-Resistant Nephrotic Syndrome
  25. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells
  26. Biological Variability of Estimated GFR and Albuminuria in CKD
  27. Corrigendum: Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early Diabetic Kidney Disease
  28. Glomerular Endothelial Cell Stress and Cross-Talk With Podocytes in Early Diabetic Kidney Disease
  29. WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion
  30. Diabetic Kidney Disease Susceptibility: Endothelial Mitochondrial Dysfunction as Essential Mediator
  31. DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing
  32. Shift in Focus-To Explore the Role of the Endothelium in Kidney Disease
  33. Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases
  34. Dendrin Ablation Prolongs Life Span by Delaying Kidney Failure
  35. Microvascular Endothelial Cells Poised to Take Center Stage in Experimental Renal Fibrosis
  36. Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium
  37. Krüppel-like factor 6 regulates mitochondrial function in the kidney
  38. TGFβ-Induced Actin Cytoskeleton Rearrangement in Podocytes Is Associated with Compensatory Adaptation of Mitochondrial Energy Metabolism
  39. Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro
  40. Mo1714 Designer Thiopurine Analogues for Optimized Immunosuppressive Therapy of Inflammatory Bowel Disease
  41. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis
  42. Big Apple Covets Big Biotech Presence
  43. Novel Filtration Markers as Predictors of All-Cause and Cardiovascular Mortality in US Adults
  44. Sa1781 Thiopurine Analogues for Optimized RAC1/Vav1 Blockade in Inflammatory Bowel Diseases
  45. Epithelial Cell TGFβ Signaling Induces Acute Tubular Injury and Interstitial Inflammation
  46. Transforming Growth Factor-β, Bioenergetics, and Mitochondria in Renal Disease
  47. 6-Thioguanine damages mitochondrial DNA and causes mitochondrial dysfunction in human cells
  48. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation
  49. S1775 Development of a New Class of Thiopurine-Based Immunosuppressive Agents: Improved Ratio Between High Immunosuppressive Effects and Low Associated Toxicity
  50. T-lymphocyte-induced, fas-mediated apoptosis is associated with early keratinocyte differentiation
  51. Immune Effector Cells Produce Lethal DNA Damage in Cells Treated with a Thiopurine
  52. Sodium butyrate induced keratinocyte apoptosis
  53. Regulation of MAPK Activation, AP-1 Transcription Factor Expression and Keratinocyte Differentiation in Wounded Fetal Skin
  54. Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells